Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization. - Wikidata - wikimedia - TriplyDB

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

http://www.wikidata.org/entity/Q33764990

about

Oxidative profiling of the failing right heart in rats with pulmonary hypertension Role of vascular endothelial growth factor signaling in Schistosoma-induced experimental pulmonary hypertension.Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases Nuclear factor κB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats.Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.Carfilzomib reverses pulmonary arterial hypertension.Signal transduction in the development of pulmonary arterial hypertension Steps forward in the treatment of pulmonary arterial hypertension: latest developments and clinical opportunities.Vitamin E Nicotinate.Novel and emerging therapies for pulmonary hypertension.Complement components as potential therapeutic targets for asthma treatment.Endothelial nanomedicine for the treatment of pulmonary disease.Animal Models of Pulmonary Hypertension: Matching Disease Mechanisms to Etiology of the Human Disease.Novel investigational therapies for treating pulmonary arterial hypertension.Lung Circulation.Adhesion Molecules: Master Controllers of the Circulatory System.The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies.New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis.A diffuse lung emphysema, severe pulmonary hypertension and lack of airflow limitation.Update on novel targets and potential treatment avenues in pulmonary hypertension.Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension.The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertension.Redox Signaling in the Right Ventricle.Dynamics of the human antibody repertoire after B cell depletion in systemic sclerosis.Vascular Endothelial Mitochondrial Function Predicts Death or Pulmonary Outcomes in Preterm Infants.Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series).Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers.Redox Biology of Right-Sided Heart Failure

P2860

Q33637652-1FC64D3B-D69E-46B0-A243-254B983DC01B Q33806046-2B47518E-5CA6-4DF3-9B9A-31CE71872269 Q33898213-5611A09B-2297-4C08-8751-377617C9ADA5 Q33920050-FC5DF2E5-2818-464E-B559-2269F1E3D674 Q33956836-225C67E2-86EB-42E7-BD15-BDB0AAD5DBD3 Q34305561-5625A4C1-0FA3-4945-BB90-D04E2E1ADF5F Q35115837-72B4EE58-DE14-4D9E-BE56-7EE38FD94E62 Q36812649-6A8F6D27-83AE-424D-B13E-07C793FE65A1 Q37133785-B9304B5E-9EA6-44AD-95D7-986034941561 Q37705261-3304B64C-3B29-4A66-8FB5-278D60303A8D Q37741233-FBD03853-FB4F-485A-96D2-E86E3F35B44E Q38176678-E571D75A-4055-41A2-8001-30F603B65F5E Q38182225-AC13C754-9FDA-4532-9D49-352FF498292C Q38267984-26874C40-1F72-4E06-B778-CD24893D814F Q38364225-E8C6F79B-C557-4105-AAC1-FFD82F1E6F49 Q38612061-EB95EED2-4140-4A96-A926-06ADD6CC811B Q38804579-6ED675F0-F488-4CCB-B8A4-1337770F056E Q38804583-ECBD5657-05FD-4339-82FC-DCD63E7B7A18 Q39353707-02836412-4A0F-405B-8582-504BCB673C60 Q41853468-84B1785C-E5B3-41AC-8E79-F870A11798D4 Q42235236-E9569ABC-9322-4C8C-ACBA-21AEE0AE0096 Q42784219-3A9745A8-8048-444E-93AA-E3088F5A9D92 Q45030673-BBF89FD1-A95B-40F0-9207-8A58AB184AF8 Q45046014-43D9A761-7A85-4A77-8903-D75C0244420D Q46175919-AA85F8DA-9E4A-4D05-A798-D720897B021C Q46280831-25C0F699-24A1-44F9-8B27-12DC27C348F7 Q47754080-3EA913E2-158E-414B-B0E3-EE6E1D8734D5 Q47897172-2A0988A3-F266-4650-ABDD-2547E3053CF2 Q52685710-AE0A16DD-B928-4FB1-A03B-C98C1C6FB813 Q55155611-78AA0F2C-8F64-4914-85B4-FFC1D9863A47 Q58795160-655BB7F7-83A6-4A12-A05C-24EE245B81D1

P2860

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

http://www.wikidata.org/entity/Q33764990

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

@ast

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

@en

type

label

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

@ast

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

@en

prefLabel

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

@ast

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

@en

P1433

Q33764990-7C8A8AEC-CA2D-4727-A368-93F0E050330E

P1476

Q33764990-FF516F75-C4AF-44D4-BD46-83AD47E6FCC2

P2093

Q33764990-1EC1A568-6D71-4368-9DD5-78ED1F81B51E

Q33764990-68C19BB1-6D40-4B4E-A4E6-E9468D72E11D

Q33764990-79E7998F-ADB2-44F0-A43F-3E2DC0A6C5E7

Q33764990-865D5EA1-A014-4E04-B5A9-6B6D2CDA2E8B

Q33764990-896D5289-6481-4A1D-B804-6D4D5D4CCD71

Q33764990-8AEE37BD-6CCF-413D-A429-1778BB87B75E

Q33764990-A6CFC2AA-3735-47B5-B396-98B514927DDF

Q33764990-C2E3D30F-16A1-46EE-A11E-EF245040B374

Q33764990-C69AD149-6216-4A1D-A03C-C4900E0585CE

Q33764990-FC802F5D-99EF-4198-98FA-EB96C6ADB4A9

P2860

Q33764990-02C3CEE4-2877-40A8-9F14-238D2081193B

Q33764990-075DD351-FEF5-4077-A607-79431DF3A6AF

Q33764990-0E1933BD-893D-451D-90F4-44DDF45553C7

Q33764990-1A348236-2DBC-4669-B87C-EEBD86D93897

Q33764990-1C7DFD69-7D11-4439-8691-4A38A6A17872

Q33764990-1D67913D-7C43-46AD-834A-63A37CAAF75F

Q33764990-1D836BBB-2BDD-491B-BDE9-8D548C06F97D

Q33764990-1E0E55C5-4E80-4FC1-A10E-A756998B41EB

Q33764990-26CB4944-10EE-4FE1-9992-6F3E48CBD5BA

Q33764990-30525C48-21E1-4FB6-9822-24F16EBCF92A

P304

Q33764990-66DC94B1-147B-4B5E-9308-1DCE3C07F6CE

P31

Q33764990-AC202510-DB9E-49A2-BB1E-9C1051A75A1F

P356

Q33764990-F5EE9690-B852-45FE-AAD2-82B6238418FC

P433

Q33764990-BB74A0F4-71A2-4F38-89A1-03457A3EA20B

P478

Q33764990-F60D9BB9-16FB-41E1-90BA-03201601F499

P577

Q33764990-69FB0830-97AE-4480-8D33-15A6F27F2354

P698

Q33764990-B3D56ED9-2C09-4F4D-8809-1AB90BE6F2F0

P921

Q33764990-2B00769A-8C39-4B2A-992E-5B93DF4FC895

P932

Q33764990-CA8D3C79-EBDE-434B-9191-2CCDDAC6015D

P356

RCMB.2012-0077OC

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

@en

P2093

Aysar Al Husseini

http://www.w3.org/2001/XMLSchema#string

Carlyne D Cool

http://www.w3.org/2001/XMLSchema#string

Daniela Farkas

http://www.w3.org/2001/XMLSchema#string

Donatas Kraskauskas

http://www.w3.org/2001/XMLSchema#string

Herman J Bogaard

http://www.w3.org/2001/XMLSchema#string

Jose Gomez-Arroyo

http://www.w3.org/2001/XMLSchema#string

Laszlo Farkas

http://www.w3.org/2001/XMLSchema#string

Mark R Nicolls

http://www.w3.org/2001/XMLSchema#string

Norbert F Voelkel

http://www.w3.org/2001/XMLSchema#string

Shiro Mizuno

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical classification of pulmonary hypertension.

Updated clinical classification of pulmonary hypertension.

Effect of a serotonin receptor antagonist on interleukin-6-induced pulmonary hypertension in rats.

Plexogenic arteriopathy.

Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report.

Pulmonary hypertension associated with connective tissue disease.

Inflammation in pulmonary arterial hypertension.

Fibroblast and endothelial apoptosis in systemic sclerosis.

Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.

Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung.

P304

679-687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/RCMB.2012-0077OC

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22842496

http://www.w3.org/2001/XMLSchema#string

P921

P932

5459528

http://www.w3.org/2001/XMLSchema#string